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Abstract
Background: Some studies have shown that hypoglycemic episodes in diabetic patients might be associated with
increased cardiovascular events. It is not clear whether episodes of silent hypoglycemia had greater prognostic
value on cardiac events compared with normoglycemia or hyperglycemia in non-diabetic patients, so the aim of
this study was to investigate the association of silent hypoglycemia and cardiac events in non-diabetic patients
with acute ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary
intervention (p-PCI).
Methods: We enrolled non-diabetic patients with STEMI who underwent p-PCI and whose clinical and laboratory
data were collected. Interstitial glucose values were recorded using a continuous glucose monitoring system
(CGMS), and Holter monitoring was recorded for 3 days in parallel. Cardiac ischemia and ventricular arrhythmia was
evaluated.
Results: Based on the inclusion and exclusion criteria, we enrolled 164 STEMI patients undergoing p-PCI for final
analysis. A total of 280 episodes of silent hypoglycemia (CGMS glucose <70 mg/dl) were recorded. Episodes of silent
cardiac ischemia were recorded in 50 of 280 hypoglycemic episodes. The incidence of silent cardiac ischemia during
hypoglycemia was significantly higher than the incidence during both hyperglycemia and normoglycemia(P < 0.01).
Moreover, we found a significantly higher frequency of ventricular extrasystoles (VESs) or nonsustained ventricular
tachycardias (NSVTs) in patients with silent hypoglycemia. The average number of events of silent cardiac ischemia was
also significantly increased in the silent hypoglycemia group (0.91 ± 0.82 vs. 0.35 ± 0.54, P < 0.01) compared with either
hyperglycemia or normoglycemia group.
Conclusions: Hypoglycemia was frequent and most of the time asymptomatic in non-diabetic patients with STEMI
undergoing p-PCI. Silent hypoglycemia was associated with silent cardiac ischemia. STEMI patients with silent
hypoglycemia had a significantly higher frequency of VESs or NSVTs.
Keywords: ST-segment elevation myocardial infarction, Primary percutaneous coronary interventions, Continuous
glucose monitoring system, Silent hypoglycemia
* Correspondence: azzyj12@163.com
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical
University, Beijing Institute of Heart Lung and Blood Vessel Disease, the Key
Laboratory of Remodeling-related Cardiovascular Disease, Ministry of
Education, Beijing 100029, China
© 2016 Zhang and Zhou. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang and Zhou BMC Cardiovascular Disorders  (2016) 16:75 
DOI 10.1186/s12872-016-0245-z
Background
Glycemic management in subjects with acute myocardial
infarction (AMI) remains controversy. The general con-
sensus in present is that hyperglycemia (>10 mmol/L)
and hypoglycemia (<3.9 mmol/L) should be avoided for
critically ill patients [1]. AMI patients with hypoglycemia
appeared to have worse outcomes [2–4]. Pinto et al. [3]
thought an admission blood glucose <4.5 mmol/L had a
3-fold increased rate of adverse outcomes in patients
with ST-segment elevation myocardial infarction (STEMI).
Moreover, a previous study showed that spontaneous
hypoglycemia was associated with a 2-fold increased in-
hospital mortality in AMI patients [4]. Many studies [5, 6]
showed that hypoglycemia was common in patients with
type 2 diabetes and the vast majority of hypoglycemic
episodes were asymptomatic and occurred at night.
Moreover, with the use of continuous glucose monitoring
systems (CGMS), which could monitor hypoglycemia con-
veniently, by simultaneously equipping subjects with
CGMS and Holter monitoring, Chow et al. [5] revealed
that hypoglycemia was associated with possible ischemic
changes and various cardiac arrhythmias, suggesting that
these events could be interconnected.
Previous studies have focused on the prognostic effects
of iatrogenic hypoglycemia in diabetic patients. However,
there have been few studies examining hypoglycemia-
induced arrhythmias and cardiac ischemia in non-diabetic
patients with STEMI undergoing primary percutaneous
coronary intervention (p-PCI). Our previous study have
approved that the use of CGMS was feasible and safety in
STEMI subjects undergoing p-PCI Therefore, with the
use of CGMS and Holter monitoring in parallel, the aim
of this study was to investigate the association of silent
hypoglycemia and cardiac events in non-diabetic subjects
with STEMI who underwent p-PCI.
Methods
Study design and patient population
This study was conducted from January 2012 to November
2013. After admission, information about previous clinical
history, cardiovascular risk factors, and medication were
collected. Moreover, laboratory and echocardiography data
were recorded. The inclusion criteria were as follows: 1)
confirmed admission diagnosis of STEMI and undergoing
p-PCI; 2) admission glucose <22.2 mmol/l and no history
of diabetes; and 3) written informed consent. The exclusion
criteria included: 1) a history of hepatic or renal im-
pairment or of other diseases that could influence
glucose metabolism,including malnutrition and cancer;
and 2) a history of diabetes, cardiac pacing,or ven-
tricular arrhythmia. The study protocol was approved
by the Medical Ethics Committee of Beijing Anzhen
Hospital, Beijing Daxing Hospital, Capital Medical
University.
Definition of hypoglycemia and hyperglycemia
Silent hypoglycemia was defined by no typical symptoms
of hypoglycemia being noted, but the plasma glucose
concentration was <3.9 mmol/l (70 mg/dl) [7].
Hyperglycemia (stress hyperglycemia) was defined as a
plasma glucose concentration of at least 10 mmol/l
(180 mg/dl) [8, 9].
CGMS and holter
All of the patients were equipped with CGMS (Medtronic
Mini-Med, USA) and were monitored for 72 consecutive
hours after p-PCI. A CGMS sensor was inserted in the ab-
dominal subcutis and was calibrated every 6 h according to
the manufacturer’s indications. blood glucose levels of each
patient was examined by a self-monitoring of blood glucose
(SMBG) device (Medisafe Mini, Terumo, Japan) at least 4
times per day. The sensor measures interstitial glucose
every 10 s and records the mean values at 5-min intervals.
The sensor remained in place for 3 days for the collection
of data, having been adapted from previously established
criteria for optimal accuracy of the CGMS [10, 11].
Holter was used to monitor for cardiac ischemia and
arrhythmia simultaneously. Continuous glucose and
Holter monitoring was performed over a period of 72 h.
The CGMS and Holter were removed after 72 h.
The Holter monitoring recordings were read by a car-
diologist, and the glucose monitoring results were read
by an endocrinologist, both of whom were blinded to
the other’s results.
Definitions of cardiac ischemia and ventricular arrhythmia
Silent cardiac ischemia was defined as no typical symptoms
of chest pain being noted, but ischemic ECG abnormalities
were recorded. Ischemic ECG abnormalities included ST-
segment depression and T-wave abnormalities. ST-segment
abnormalities indicative of ischemia were defined as flat or
down-sloping segment depressions with ST-J depres-
sion of ≥1.0 mm in ≥2 adjacent leads. T-wave abnormal-
ities indicative of ischemia were defined as any negative or
biphasic T-wave in ≥2 contiguous leads [12].
Ventricular arrhythmia included ventricular extrasys-
toles (VESs), couplets, triplets, and ventricular tachycar-
dias (VTs).
All of the cardiac event data were adjudicated by an
experienced cardiovascular physician blinded to the clin-
ical details and outcomes.
Statistical analysis
CGM parameters were analyzed using Medtronic MiniMed
CGMS software, version 3.0. The data are presented as
frequencies and percentages for categorical variables and as
the mean ± SD for continuous variables. We used the χ2
test to compare the categorical variables, and the 2-sample
t test for continuous variables. Hypoglycemic and
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hyperglycemic episodes were compared with episodes of si-
lent cardiac ischemia or typical angina. Hypoglycemic and
hyperglycemic episodes occurring within the preceding
30 min of an ischemic event were noted [13]. Statistical
analysis was performed using the Yates-corrected χ2 test. A
P value <0.05 (two-sided) was considered significant. The
data were analyzed with SPSS software, version 21.0
(Chicago, Illinois, USA).
Results
Based on the inclusion and exclusion criteria, we enrolled
172 STEMI patients undergoing p-PCI, and six cases were
excluded for final analysis due to CGMS signal interrup-
tion or failure to meet the accuracy requirements. Two
cases with symptomatic hypoglycemia were also excluded.
Data from the remaining 164 subjects (115 men and 49
women) were incorporated into the statistical analysis.
Table 1 provides the basic characteristics and CGMS
features of the study patients. The mean number of epi-
sodes of hypoglycemia per patient was 1.7 ± 1.8, and the
mean number of episodes of hyperglycemia per patient
was 2.4 ± 2.7. The mean duration of hypoglycemia per
patient was 1.6 ± 3.0 h, and the mean duration of hyper-
glycemia per patient was 2.5 ± 3.9 h.
A total of 280 episodes of silent hypoglycemia (CGMS
glucose <70 mg/dl) were recorded. Episodes with silent
cardiac ischemia were recorded in 50 out of 280
hypoglycemic episodes. Episodes with typical angina
were found in 23 of 280 hypoglycemic episodes (Table 2).
Hyperglycemia (CGMS glucose >180 mg/dl) occurred a
total of 473 times. Of these 473 episodes of hyperglycemia,
32 silent cardiac ischemia was noted, and 20 episodes of
typical angina occurred. There were seven episodes of silent
cardiac ischemia and five episodes of typical angina during
normoglycemia (Table 2). The difference between the fre-
quency of silent cardiac ischemia during hypoglycemia and
the frequency during both hyperglycemia and normogly-
cemia was statistically significant (P < 0.01). The difference
between the frequency of typical angina episodes with silent
hypoglycemia and with both hyperglycemia and normogly-
cemia was also statistically significant (P < 0.01) (Table 2).
Table 3 shows the relationship between silent
hypoglycemia and cardiac events over 3 days of parallel
recording. Three patients were excluded due to frequent
malignant arrhythmia, which was treated with medica-
tion intervention or electroversion. We divided the
whole study population into a silent hypoglycemia group
(n = 55) and non-silent hypoglycemia group (n = 105).
Mean QTc, as well as couplets per patient, triplets per
patient, and SVTs (sustained ventricular tachycardias)
per patient, was not different; however, we found a sig-
nificantly higher frequency of VESs or NSVTs (nonsus-
tained ventricular tachycardias) in patients with silent
hypoglycemia. Moreover, the average number of silent
cardiac ischemia was significantly higher in the silent
hypoglycemia group (0.91 ± 0.82 vs. 0.35 ± 0.54, P < 0.01).
Discussion
It is commonly accepted knowledge that CGMS can
detect a significantly greater number of hypoglycemic
episodes than repeated capillary blood glucose testing.
Several studies have reported that the incidence of
hypoglycemia in non-diabetic patients was rare [14–16].
However, non-diabetic hypoglycemia was common in crit-
ical care settings [17, 18]. With the use of CGMS, Chow
et al. [5] found that in diabetic subjects hypoglycemia was
frequently asymptomatic and may increase the risk of ar-
rhythmias. In our study, we also found that hypoglycemia




Age (years) 53 ± 15
Males 115(70)
BMI, kg/m2 24.7 ± 4.1
LVEF, % 54.2 ± 7.4
HbA1c (%) 5.1 ± 1.0
Glycated albumin (%) 12.8 ± 4.6








MBG(mmol/l) 6.6 ± 0.8
MAGE (mmol/l) 2.8 ± 1.6
SDBG(mmol/l) 1.4 ± 0.5
The number of Mean episodes of hypoglycemia per patient 1.7 ± 1.8
The numberof Mean episodes of hyperglycemia per patient 2.4 ± 2.7
Mean duration of hypoglycemia per patient (h) 1.6 ± 3.0





Main stem involved 20(12)
Multivessel 93(57)
Data given as mean ± SD or n (%)
BMI body mass index, LVEF left ventricularejectionfraction, HbA1c Hemoglobin
A1c, MBG Mean blood glucose, MAGE the mean amplitude of glycemic
excursions, SDBG the standard deviation of blood glucose values
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was frequent and most of the time asymptomatic in non-
diabetic patients with STEMI undergoing p-PCI in the
cardiac intensive care unit.
Recent studies have shown that symptomatic severe
and mild hypoglycemia were associated with increased
cardiovascular events [19, 20]. However, the impact of
silent hypoglycemia on cardiac adverse events in AMI
patients remains unclear. Based on the availability of
CGMS, combined with continuous ECG monitoring,
which makes it possible to examine the relationships be-
tween hypoglycemia and cardiac adverse events, Cyrus
Desouza et al. [13] found that silent hypoglycemia was
more likely to be associated with cardiac ischemia than
normoglycemia and hyperglycemia in diabetic patients.
In our study we also found that silent hypoglycemia was
associated with silent cardiac ischemia. Our results indi-
cated that AMI patients with silent hypoglycemia might
be associated with poorer outcomes
Our investigations of parallel recording of CGMS and
ECG revealed a high incidence of both silent hypoglycemia
episodes and silent ventricular arrhythmias in non-diabetic
patients with STEMI undergoing p-PCI. However, symp-
tomatic hypoglycemia and severe symptomatic ventricular
arrhythmias were rare. Previous studies [21, 22] have also
shown that the incidence of serious arrhythmias was very
low in AMI patients after successful early revascularization.
Moreover, in our study we detected a significantly higher
frequency of VESs and NSVTs in patients with silent
hypoglycemia. The incidence of SVTs in non-diabetic pa-
tients with STEMI undergoing p-PCI was very low. These
silent ventricular arrhythmias occurred more often at night
than during daytime. Our foundings are similar to those of
previous studies [5, 6].
Some potential mechanisms of which hypoglycemia
might lead to myocardial ischemia and arrhythmias have
been listed: increasing sympathetic activity which can in-
duce vasoconstriction and platelet aggregation and conse-
quently ischemia [23],a rise in some markers of endothelial
dysfunction, such as VIII factor,von Willebrand factor, in-
terleukins, cytokines levels, and increases in endothelin-1
and reactive oxygen species [24–26]; a prolongation
in QT-segment,activation of the sympathoadrenal system
and the production of proarrhythmogenic catecholamines,
which can cause ventricular arrhythmias [23, 27, 28].
Following the use of CGMS, silent hypoglycemia could
be conveniently monitored. Although the prognostic value
of silent hypoglycemia in AMI patients remains controver-
sial, it might be an important predictor of cardiac events
after AMI. Further studies are needed to investigate the
mechanisms, prognostic value and therapeutic strategies.
There were several limitations to this study. First, the
number of patients was relatively small so that compari-
sons of some subgroups might be lack of power to detect
significant differences for selected variables. Second, many
of the AMI patients were on β-blockers, which can mask
catecholamine-induced symptoms and increase episodes
of silent hypoglycemia and silent ischemia. Third, the re-
sults of CGMS sometimes are unstable; moreover, this
was an observational study and reflected only a possible
association of silent hypoglycemia and cardiac events.
Hence, the results of the present study should be inter-
preted with caution.
Conclusions
Hypoglycemia was frequent and, most of the time,
asymptomatic in non-diabetic patients with STEMI
Table 2 CGMS and Holter monitoring abnormalities
Total episodes Episodes with silent cardiac ischemia Episodes with typical angina
Silent Hypoglycemia 280 50* 23*
Normoglycemia N/A 7 * 5*
Hyperglycemia 473 32 * 20*
*P < 0.01
Table 3 Relationship between silent hypolycemia and cardiac events during 3 days of parallel recording
Silent hypolycemia (n = 55) No Silent hypolycemia (n = 106) P
Silent cardiac ischemia 0.91 ± 0.82 0.35 ± 0.54 0.001
Mean QTc(ms) 391.4 ± 55.3 384.6 ± 51.7 0.441
VESs per patient(n) 4681 ± 6784 2685 ± 4378 0.048
Couplets per patient(n) 28.4 ± 58.1 20.7 ± 50.3 0.384
Triplets per patient(n) 3.4 ± 7.2 2.1 ± 6.4 0.244
NSVTs per patient(n) 2.8 ± 5.7 1.1 ± 3.5 0.043
SVTs per patient(n) 0.11 ± 0.37 0.06 ± 0.23 0.337
VESs ventricular extrasystoles, VTs ventricular tachycardias, NSVTs nonsustained ventricular tachycardias, SVTs sustained ventricular tachycardias
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undergoing p-PCI. Silent hypoglycemia was associated
with silent cardiac ischemia. AMI patients with silent
hypoglycemia had a significantly higher frequency of
VESs or NSVTs.
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